BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23043422)

  • 21. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg) 2006; 93; 872-878.
    Capussotti L; Muratore A
    Br J Surg; 2006 Dec; 93(12):1564; author reply 1564. PubMed ID: 17115402
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC).
    Berretta M; Zanet E; Nasti G; Lleshi A; Frustaci S; Fiorica F; Bearz A; Talamini R; Lestuzzi C; Lazzarini R; Fisichella R; Cannizzaro R; Iaffaioli RV; Berretta S; Tirelli U
    Arch Gerontol Geriatr; 2012; 55(2):271-5. PubMed ID: 21937127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
    Kornmann M; Fakler H; Butzer U; Beger HG; Link KH
    Anticancer Res; 2000; 20(5A):3259-64. PubMed ID: 11062751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
    J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronic acid as a marker of sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy for colorectal liver metastases: don't forget the tumor.
    Rahbari NN; Weitz J
    Ann Surg Oncol; 2013 May; 20(5):1405-7. PubMed ID: 23463087
    [No Abstract]   [Full Text] [Related]  

  • 26. A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.
    Hewes JC; Riddy D; Morris RW; Woodrooffe AJ; Davidson BR; Fuller B
    J Hepatol; 2006 Aug; 45(2):263-70. PubMed ID: 16635536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effect of mFOLFOX6 for synchronous unresectable liver metastases from colorectal cancer].
    Chikatani K; Ishibashi K; Tajima Y; Hatano S; Amano K; Ishiguro T; Kuwabara K; Sobajima J; Ohsawa T; Okada N; Kumamoto K; Haga N; Iwama T; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2211-3. PubMed ID: 22202333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.
    Fiorentini G; Rossi S; Dentico P; Meucci F; Bonechi F; Bernardeschi P; Cantore M; Guadagni S; De Simone M
    Anticancer Res; 2004; 24(3b):2093-6. PubMed ID: 15274406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
    Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing paradigms for liver resection of colorectal metastases.
    Kemeny NE
    Ann Surg Oncol; 2012 Sep; 19(9):2773-5. PubMed ID: 22752377
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version.
    Zalinski S; Mariette C; Farges O; ; ;
    J Visc Surg; 2011 Jun; 148(3):e171-82. PubMed ID: 21703959
    [No Abstract]   [Full Text] [Related]  

  • 33. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases.
    Ward J; Guthrie JA; Sheridan MB; Boyes S; Smith JT; Wilson D; Wyatt JI; Treanor D; Robinson PJ
    J Clin Oncol; 2008 Sep; 26(26):4304-10. PubMed ID: 18779617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [State of art of the radiofrequency ablation of colorectal liver metastases].
    Zhao M; Wang JP; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):401-4. PubMed ID: 21875477
    [No Abstract]   [Full Text] [Related]  

  • 35. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice.
    Gonzalez-Aparicio M; Alzuguren P; Mauleon I; Medina-Echeverz J; Hervas-Stubbs S; Mancheno U; Berraondo P; Crettaz J; Gonzalez-Aseguinolaza G; Prieto J; Hernandez-Alcoceba R
    Gut; 2011 Mar; 60(3):341-9. PubMed ID: 20855451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response.
    Kern W; Beckert B; Lang N; Waggershauser T; Braess J; Schalhorn A; Hiddemann W
    Anticancer Res; 2000; 20(6D):4973-5. PubMed ID: 11326650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sinusoidal obstruction syndrome in the animal model: influence on liver surgery.
    Jafari A; Wehner S; Kalff JC; Manekeller S
    Langenbecks Arch Surg; 2017 Feb; 402(1):115-122. PubMed ID: 27585678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Steatohepatitis after chemotherapy for colorectal liver metastases (CASH)].
    Tannapfel A; Reinacher-Schick A; Flott-Rahmel B
    Pathologe; 2011 Jul; 32(4):330-5. PubMed ID: 21681471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
    Cayet S
    Eur J Radiol; 2018 Mar; 100():155. PubMed ID: 29422354
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
    Huang ZQ; Yang HF; Lin W; Xu L
    Eur J Radiol; 2018 Mar; 100():154. PubMed ID: 29395618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.